N-(cyanomethyl)-4-methylbenzenesulfonamide, 97%, 10g

Diphenyl[4-(phenylthio)phenyl]sulfonium Hexafluoroantimonate>98.0%(HPLC)1g

3-Hydroxypentanenitrile, 95%, 5g

[5,5'-Bis(trifluoromethyl)-2,2'-bipyridine-kappa~2~N~1~,N~1'~][bis[3,5-difluoro-2-[5-(trifluoromethyl)-2-pyridinyl-kappaN]phenyl-kappaC~1~]]iridium Hexafluorophosphate>95.0%(HPLC)(qNMR)500mg

2-Bromo-9,9-dimethyl-5-phenyl-9H-fluorene, 98%, 25g

{[(4-fluorophenyl)methyl]sulfanyl}methanimidamide hydrobromide, 95.0%, 1g

Rink Amide MBHA resin (100-200 mesh) 0.3-0.8mmol/g 1% DVB, 95+%, 25g

2-Methoxy-5-methylnicotinic acid, 97%, 250mg

(2-Ethoxy-5-(trifluoromethyl)pyridin-3-yl)boronic acid, 95.0%, 5g

3,3-azetidinediyldimethanol hydrochloride, 95.0%, 250mg

2-(3,5-Dimethylbenzoyl)-3-methylpyridine, 97.0%, 1g

(R)-1-(2-Methoxypyridin-4-yl)ethanamine dihydrochloride, 95.0%, 250mg

6-Methoxypyridazin-4-amine, 98%, 5g